Trade IBIO anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
iBio, Inc. (IBIO) is trading at US$1.37, down 2.50% today as of Aug 28, 09:39 EDT. The company has a market capitalisation of US$71.04M. Over the past 52 weeks, IBIO has traded between US$0.77 and US$3.82. On Syfe you can trade IBIO with $0 commission and add it to your watchlist.
| Previous close | US$1.40 |
|---|---|
| Market cap | US$71.04M |
| 52-week range | US$0.77 – US$3.82 |
| Volume | 374.4K |
| Exchange | US |
Add to Watchlist
Set Price Alert
iBio, Inc.
iBio, Inc. is an AI-driven innovator that develops next-generation biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard to target cancers, and other diseases. It focuses on decreasing drug failures, shortening drug development timelines and opening up new frontiers against the most promising targets. The company was founded on April 17, 2008 and is headquartered in San Diego, CA.
Year: 2008
Raymond James Initiates iBio at Outperform With $5 Price Target
Jun 8, 11:06 AM · MT Newswires
B. Riley Initiates iBio at Buy With $6 Price Target
Jun 5, 11:55 AM · MT Newswires
iBio, Inc. (IBIO) stock is trading at US$1.37, -2.50% from the previous close of US$1.40.
The market cap for iBio, Inc. (IBIO) stock is approximately US$71.04M.
The 52-week high for iBio, Inc. (IBIO) stock is US$3.82.
The 52-week low for iBio, Inc. (IBIO) stock is US$0.77.
iBio, Inc. (IBIO) does not currently pay a dividend.
Stay on top of IBIO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
